Announced Mon, 22 Jun · 16:05 IST
Promoters confirm no share encumbrance in FY25
Ownership Changes View source PDF
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.6%1-day move
₹678.00
prior close
₹680.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.9+1.9+1.7+6.6+4.6+3.1+0.0+0.3+3.6+4.1+6.0-2.7——
Up moveDown movePending
AI summary
Promoter Chandrakant Vallabhaji Gogri has filed an annual declaration under SEBI Regulation 31(4) of the Takeover Regulations, 2011, confirming that none of the promoters, promoter group members, or persons acting in concert created any encumbrance (pledge, lien, or charge) on the shares of Aarti Pharmalabs during Financial Year 2024-25. The filing includes the full list of promoter and promoter group entities. This is a routine yearly compliance submission.
Likely market impact
Positive compliance signal — no new promoter pledges or encumbrances created in FY25, indicating stable and unencumbered promoter shareholding.